The patients with following disease conditions the drug Etomidate is ideally used for general anesthesia

RRB Nsg Superintendent -29 April 2025 (Shift-1st)

Pharmacology

Easy

Appeared in: RRB Nsg Superintendent -29 April 2025 (Shift-1st)

Explanation

Etomidate is an intravenous anesthetic agent specifically chosen for its minimal impact on the cardiovascular system.
It provides excellent hemodynamic stability, causing little to no change in heart rate, blood pressure, or cardiac output upon induction.
This makes it the ideal choice for patients with pre-existing cardiovascular conditions like coronary artery disease, heart failure, or valvular disease, where maintaining stable hemodynamics is critical.
It is considered a safer alternative to other agents like propofol, which can cause significant hypotension, in patients with compromised myocardial contractility.

Option B: While Etomidate decreases intracranial pressure, it is not ideal for patients with neurological problems because it can cause involuntary muscle movements (myoclonus) and may activate seizure foci.
Option C: There is no specific advantage of using Etomidate for patients with gastrointestinal problems. The choice of anesthetic would depend on other comorbidities, not the GI condition itself.
Option D: Similar to GI problems, there is no specific indication for using Etomidate in patients undergoing orthopedic procedures unless they have underlying cardiovascular instability.

Visual 1: Chart: Comparative Hemodynamic Effects of Induction Agents. A bar chart showing the typical percentage change in Mean Arterial Pressure (MAP) and Heart Rate (HR) after administration of Etomidate, Propofol, and Ketamine. Etomidate's bars would be close to zero, Propofol's would show a significant drop in MAP, and Ketamine's would show a significant increase in both MAP and HR.

Clinical Relevance

Nursing practice connection: Knowing Selection of anesthetic agents based on patient comorbidities helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
A nurse assisting in anesthesia must be aware of Etomidate's profile to anticipate patient responses. The primary expectation is cardiovascular stability, but the nurse should also be prepared to manage potential side effects like myoclonus.
Monitoring for adrenal suppression is crucial, although it's a transient effect from a single dose. In patients receiving multiple doses or those who are critically ill (e.g., with sepsis), the nurse should be vigilant for signs of adrenal insufficiency like hypotension and electrolyte imbalances.
What if? If the patient with cardiovascular disease is also septic, the choice of Etomidate becomes more complex. While its hemodynamic stability is a major benefit, the risk of worsening adrenal suppression in a septic patient is a serious concern. The anesthesia provider might still use it but with extreme caution, or opt for an alternative like ketamine if the patient's blood pressure is low.

How to Approach the Question

First, identify the core of the question: it asks for the ideal use of the drug Etomidate.
Recall or look up the key characteristic of Etomidate. Its most defining feature in anesthesia is its cardiovascular stability.
Analyze the options provided. Each option is a patient population with a specific type of health problem.
Match the drug's key feature to the patient population that would benefit most from it. Cardiovascular stability is most beneficial to patients with cardiovascular problems.
Consider why it would be less ideal for the other groups. For neuro problems, think about CNS side effects (myoclonus). For GI/Ortho, recognize there's no specific link, making the choice dependent on other factors.

Concept Tested & Keywords

QiXn6CBfys8ngLWBAaAmH6